PAIN THERAPEUTICS INC's ticker is PTIE and the CUSIP is 69562K100. A total of 66 filers reported holding PAIN THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $12,000 | -92.3% | 13,700 | -91.2% | 0.00% | -100.0% |
| Q3 2016 | $156,000 | +372.7% | 156,067 | +923.2% | 0.00% | +300.0% |
| Q2 2016 | $33,000 | -47.6% | 15,253 | -57.8% | 0.00% | 0.0% |
| Q4 2015 | $63,000 | -3.1% | 36,103 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $65,000 | +27.5% | 35,459 | +19.5% | 0.00% | 0.0% |
| Q2 2015 | $51,000 | -51.9% | 29,670 | -43.4% | 0.00% | -50.0% |
| Q4 2014 | $106,000 | -48.5% | 52,375 | +46.1% | 0.00% | -33.3% |
| Q2 2014 | $206,000 | – | 35,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,797,689 | $13,597,000 | 9.60% |
| SOPHROSYNE CAPITAL LLC | 1,265,020 | $6,147,000 | 5.38% |
| Madison Street Partners, LLC | 976,653 | $4,747,000 | 4.46% |
| INTREPID CAPITAL MANAGEMENT INC /DE/ | 460,000 | $2,236,000 | 2.28% |
| Broadfin Capital, LLC | 1,230,000 | $5,978,000 | 0.79% |
| 683 Capital Management, LLC | 427,071 | $2,076,000 | 0.59% |
| AVALON CAPITAL MANAGEMENT | 138,520 | $673,000 | 0.57% |
| Cheyne Capital Management (UK) LLP | 92,700 | $451,000 | 0.49% |
| Visium Asset Management, LP | 4,350,000 | $21,141,000 | 0.42% |
| Gruss Capital Management LP | 789,811 | $3,838,000 | 0.29% |